About Contact Us Careers
Sign In

Digital Biomarker Market Analysis

  • Report ID: 3217
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Global Digital Biomarker Market TOC

  1. An Outline of the Global Digital Biomarker Market
    1. Market Definition
    2. Market Segmentation
    3. Industry Overview
  2. Assumptions & Abbreviations
  3. Research Methodology & Approach
    1. Research Process
    2. Primary Research
      1. Manufacturers
      2. Service Providers 
      3. End Users
    3. Secondary Research
    4. Market Size Estimation
  4. Summary of the Report for Key Decision Makers
  5. Forces of Market Constituents
    1. Factors/drivers impacting the growth of the market
    2. Market trends for better business practices
  6. Key Market Opportunities for Business Growth
  7. Major Roadblocks for the Market Growth
  8. Decarbonization Strategy and Carbon Credit Benefits for Market Players
    1. Global Government Decarbonization Plans/Goals by Each Country under 2015 Agreement Agreed by 200 Countries
    2. Measures taken by Countries to Reduce Carbon Footprints
    3. Carbon Credits and Subsidy Plans/Benefits Rolled out by the Government for Market Players
    4. Effective Ways to Harness Carbon-Credits and Impact on Profit Margins
    5. Demand Impact on the Companies Opting for Carbon Credits
  9. Government Regulation: How They Would aid Business?
  10. Industry Risk Analysis
  11. Global Economic Outlook: Challenges for Global Recovery and its Impact on Global Digital Biomarker Market
    1. Ukraine-Russia crisis
    2. Potential US economic slowdown
  12. Pipeline Analysis
  13. Industry Growth Outlook
  14. Industry Value Chain Analysis
  15. End User Analysis
  16. Competitive Positioning: Strategies to Differentiate a Company From its Competitor
  17. Competitive Model: A Detailed Inside View for Investors
    1. Company Market Share (2023)
    2. Business Profile of Key Enterprise
    3. nQ Medical
      1. ALTOIDA
      2. ActiGraph, LLC
      3. VivoSense
      4. EVOCAL Health GmbH
      5. Koneksa
      6. Cosinuss GmbH
      7. Biofourmis
      8. Lunit Inc.
      9. IMVARIA Inc.
  18. Global Digital Biomarker Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Year-on-Year (YoY) Growth Trend Analysis
      1. Global Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Component
        1. Data Collection Tools, Market Value (USD Million) and CAGR, 2023-2036F
        2. Mobile Apps, Market Value (USD Million) and CAGR, 2023-2036F
        3. Wearables, Market Value (USD Million) and CAGR, 2023-2036F
        4. Biosensors, Market Value (USD Million) and CAGR, 2023-2036F
        5. Contact-free sensors, Market Value (USD Million) and CAGR, 2023-2036F
        6. Others, Market Value (USD Million) and CAGR, 2023-2036F
        7. Data Integration Systems, Market Value (USD Million) and CAGR, 2023-2036F
      2. Global Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Therapeutic Area
        1. Cardiovascular Diseases, Market Value (USD Million) and CAGR, 2023-2036F
        2. Neurodegenerative Disorders, Market Value (USD Million) and CAGR, 2023-2036F
          1. Parkinson’s Disease, Market Value (USD Million) and CAGR, 2023-2036F
          2. Multiple Sclerosis, Market Value (USD Million) and CAGR, 2023-2036F
          3. Alzheimer’s Disease, Market Value (USD Million) and CAGR, 2023-2036F
          4. Others, Market Value (USD Million) and CAGR, 2023-2036F
        3. Sleep and Movement Diseases, Market Value (USD Million) and CAGR, 2023-2036F
        4. Chronic Pain, Market Value (USD Million) and CAGR, 2023-2036F
        5. Gastrointestinal Diseases, Market Value (USD Million) and CAGR, 2023-2036F
        6. Diabetes, Market Value (USD Million) and CAGR, 2023-2036F
        7. Respiratory Conditions, Market Value (USD Million) and CAGR, 2023-2036F
        8. Other Diseases, Market Value (USD Million) and CAGR, 2023-2036F
      3. Global Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Application
        1. Wellness, Market Value (USD Million) and CAGR, 2023-2036F
        2. Disease Diagnosis, Market Value (USD Million) and CAGR, 2023-2036F
        3. Personalized Medication, Market Value (USD Million) and CAGR, 2023-2036F
        4. Drug Discovery and Development, Market Value (USD Million) and CAGR, 2023-2036F
      4. Global Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By End User
        1. Biopharmaceutical Companies & Labs, Market Value (USD Million) and CAGR, 2023-2036F
        2. Healthcare Providers, Market Value (USD Million) and CAGR, 2023-2036F
        3. Others, Market Value (USD Million) and CAGR, 2023-2036F
      5. Global Digital Biomarker Market Segmentation Analysis (2023-2036) By Geography
        1. North America, Market Value (USD Million) and CAGR, 2023-2036F
        2. Europe, Market Value (USD Million) and CAGR, 2023-2036F
        3. Asia Pacific, Market Value (USD Million) and CAGR, 2023-2036F
        4. Latin America, Market Value (USD Million) and CAGR, 2023-2036F
        5. Middle East & Africa, Market Value (USD Million) and CAGR, 2023-2036F
  19. Cross Analysis of Components w.r.t. Application (USD Million), 2023
  20. North America Digital Biomarker Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Year-on-Year (YoY) Growth Trend Analysis
      1. North America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Component
        1. Data Collection Tools, Market Value (USD Million) and CAGR, 2023-2036F
        2. Mobile Apps, Market Value (USD Million) and CAGR, 2023-2036F
        3. Wearables, Market Value (USD Million) and CAGR, 2023-2036F
        4. Biosensors, Market Value (USD Million) and CAGR, 2023-2036F
        5. Contact-free sensors, Market Value (USD Million) and CAGR, 2023-2036F
        6. Others, Market Value (USD Million) and CAGR, 2023-2036F
        7. Data Integration Systems, Market Value (USD Million) and CAGR, 2023-2036F
      2. North America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Therapeutic Area
        1. Cardiovascular Diseases, Market Value (USD Million) and CAGR, 2023-2036F
        2. Neurodegenerative Disorders, Market Value (USD Million) and CAGR, 2023-2036F
          1. Parkinson’s Disease, Market Value (USD Million) and CAGR, 2023-2036F
          2. Multiple Sclerosis, Market Value (USD Million) and CAGR, 2023-2036F
          3. Alzheimer’s Disease, Market Value (USD Million) and CAGR, 2023-2036F
          4. Others, Market Value (USD Million) and CAGR, 2023-2036F
        3. Sleep and Movement Diseases, Market Value (USD Million) and CAGR, 2023-2036F
        4. Chronic Pain, Market Value (USD Million) and CAGR, 2023-2036F
        5. Gastrointestinal Diseases, Market Value (USD Million) and CAGR, 2023-2036F
        6. Diabetes, Market Value (USD Million) and CAGR, 2023-2036F
        7. Respiratory Conditions, Market Value (USD Million) and CAGR, 2023-2036F
        8. Other Diseases, Market Value (USD Million) and CAGR, 2023-2036F
      3. North America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Application
        1. Wellness, Market Value (USD Million) and CAGR, 2023-2036F
        2. Disease Diagnosis, Market Value (USD Million) and CAGR, 2023-2036F
        3. Personalized Medication, Market Value (USD Million) and CAGR, 2023-2036F
        4. Drug Discovery and Development, Market Value (USD Million) and CAGR, 2023-2036F
      4. North America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By End User
        1. Biopharmaceutical Companies & Labs, Market Value (USD Million) and CAGR, 2023-2036F
        2. Healthcare Providers, Market Value (USD Million) and CAGR, 2023-2036F
        3. Others, Market Value (USD Million) and CAGR, 2023-2036F
    4. North America Digital Biomarker Market Segmentation Analysis (2023-2036) By Country
      1. US, Market Value (USD Million) and CAGR, 2023-2036F
      2. Canada, Market Value (USD Million) and CAGR, 2023-2036F
  21. Europe Digital Biomarker Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Year-on-Year (YoY) Growth Trend Analysis
      1. Europe Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Component
      2. Europe Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Therapeutic Area
      3. Europe Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Application
      4. Europe Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By End User
      5. Europe Digital Biomarker Market Segmentation Analysis (2023-2036) By Country
        1. UK, Market Value (USD Million) and CAGR, 2023-2036F
        2. Germany, Market Value (USD Million) and CAGR, 2023-2036F
        3. France, Market Value (USD Million) and CAGR, 2023-2036F
        4. Italy, Market Value (USD Million) and CAGR, 2023-2036F
        5. Spain, Market Value (USD Million) and CAGR, 2023-2036F
        6. Russia, Market Value (USD Million) and CAGR, 2023-2036F
        7. Netherlands, Market Value (USD Million) and CAGR, 2023-2036F
        8. Rest of Europe, Market Value (USD Million) and CAGR, 2023-2036F
  22. Asia Pacific Digital Biomarker Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Year-on-Year (YoY) Growth Trend Analysis
      1. Asia Pacific Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Component
      2. Asia Pacific Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Therapeutic Area
      3. Asia Pacific Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Application
      4. Asia Pacific Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By End User
      5. Asia Pacific Digital Biomarker Market Segmentation Analysis (2023-2036) By Country
        1. China, Market Value (USD Million) and CAGR, 2023-2036F
        2. Japan, Market Value (USD Million) and CAGR, 2023-2036F
        3. India, Market Value (USD Million) and CAGR, 2023-2036F
        4. Australia, Market Value (USD Million) and CAGR, 2023-2036F
        5. South Korea, Market Value (USD Million) and CAGR, 2023-2036F
        6. Singapore, Market Value (USD Million) and CAGR, 2023-2036F
        7. Rest of Asia Pacific, Market Value (USD Million) and CAGR, 2023-2036F
  23. Latin America Digital Biomarker Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Year-on-Year (YoY) Growth Trend Analysis
      1. Latin America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Component
      2. Latin America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Therapeutic Area
      3. Latin America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Application
      4. Latin America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By End User
      5. Latin America Digital Biomarker Market Segmentation Analysis (2023-2036) By Country
        1. Mexico, Market Value (USD Million) and CAGR, 2023-2036F
        2. Argentina, Market Value (USD Million) and CAGR, 2023-2036F
        3. Brazil, Market Value (USD Million) and CAGR, 2023-2036F
        4. Rest of Latin America, Market Value (USD Million) and CAGR, 2023-2036F
  24. Middle East & Africa Digital Biomarker Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Year-on-Year (YoY) Growth Trend Analysis
      1. Middle East & Africa Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Component
      2. Middle East & Africa Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Therapeutic Area
      3. Middle East & Africa Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By Application
      4. Middle East & Africa Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036, By End User
      5. Middle East & Africa Digital Biomarker Market Segmentation Analysis (2023-2036) By Country
        1. GCC, Market Value (USD Million) and CAGR, 2023-2036F
        2. Israel, Market Value (USD Million) and CAGR, 2023-2036F
        3. South Africa, Market Value (USD Million) and CAGR, 2023-2036F
        4. Rest of Middle East & Africa, Market Value (USD Million) and CAGR, 2023-2036F

Digital Biomarker Market Analysis

Therapeutic Area (Cardiovascular Diseases, Neurodegenerative Disorders, Sleep & Movement Diseases, Chronic Pain, Gastrointestinal Diseases, Diabetes, Respiratory Conditions)

The neurogenerative disorder segment in the digital biomarkers market is estimated to grow at a remarkable CAGR of 32.95% over the forecast period. The growth of the segment can be attributed to the rising cases of neurogenerative disorder. Owing to the low success rate of treatment and drugs, these diseases are continuously increasing and are becoming hard to tackle. In 2020, there were approximately 55 million people living with dementia worldwide. This figure is expected to nearly double every 20 years, hitting 78 million in 2030 and around 139 million in 2050.

Application (Wellness, Disease Diagnosis, Personalized Medication, Drug Discovery & Development)

Digital biomarkers market from the drug discovery & development segment is expected to grow at a CAGR of 32.69% till 2037. The growth of the segment is attributed to the growing discovery of new drugs and the rise in the number of clinical trials being carried out for novel drugs. As life sciences businesses expand to put money into and advance new treatments and vaccines across a wide range of disease areas, the total number of items currently being developed in human trials globally surpasses 6,000, a rise of 68% over the 2016 level.

Our in-depth analysis of the global market includes the following segments:

Component
  • Data Collection Tools
    • Mobile Apps
    • Wearables
    • Biosensors
    • Contact-Free Sensors
  • Data Integration Systems

Therapeutic Area
  • Cardiovascular Diseases
  • Neurodegenerative Disorders
    • Parkinson’s Disease
    • Multiple Sclerosis
    • Alzheimer’s Disease
  • Sleep and Movement Diseases
  • Chronic Pain
  • Gastrointestinal Diseases
  • Diabetes
  • Respiratory Conditions

Application
  • Wellness
  • Disease Diagnosis
  • Personalized Medication
  • Drug Discovery and Development

End User
  • Biopharmaceutical Companies & Labs
  • Healthcare Providers
Get more information on this report: Request Free Sample PDF
Browse Key Market Insights with Data Illustration:

Author Credits:  Radhika Pawar


  • Report ID: 3217
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of digital biomarkers is assessed at USD 4.77 billion.

The digital biomarkers market size was valued at USD 3.79 billion in 2024 and is projected to reach USD 144.84 billion by the end of 2037, registering around 32.2% CAGR during the forecast period i.e., between 2025-2037. The increasing number of clinical trials, and the rising burden of cognitive issues and chronic disorders will boost the market growth.

North America industry is poised to dominate 45% revenue share by 2037, propelled by surging cases of Alzheimer disease in the region.

The major players in the market include IMVARIA Inc., nQ Medical, ALTOIDA, ActiGraph, LLC., VivoSense, EVOCAL Health GmbH, Koneksa Health, Cosinuss GmbH, Biofourmis, Lunit Inc.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample